Mint Antacid 100

Calcium Carbonate


Jhk Inc Dba American Safety & First Aid
Human Otc Drug
NDC 73598-1142
Mint Antacid 100 also known as Calcium Carbonate is a human otc drug labeled by 'Jhk Inc Dba American Safety & First Aid'. National Drug Code (NDC) number for Mint Antacid 100 is 73598-1142. This drug is available in dosage form of Tablet, Chewable. The names of the active, medicinal ingredients in Mint Antacid 100 drug includes Calcium Carbonate - 420 mg/1 . The currest status of Mint Antacid 100 drug is Active.

Drug Information:

Drug NDC: 73598-1142
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Mint Antacid 100
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Calcium Carbonate
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Jhk Inc Dba American Safety & First Aid
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Tablet, Chewable
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:CALCIUM CARBONATE - 420 mg/1
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 02 Feb, 2000
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 14 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part331
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:JHK Inc dba American Safety & First Aid
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:313884
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0747200611420
UPC stands for Universal Product Code.
UNII:H0G9379FGK
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
73598-1142-150 PACKET in 1 BOX (73598-1142-1) / 2 TABLET, CHEWABLE in 1 PACKET02 Feb, 2000N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose antacid

Product Elements:

Mint antacid 100 calcium carbonate calcium carbonate carbonate ion acacia magnesium stearate maltodextrin sucrose az036 mint antacid 250 calcium carbonate calcium carbonate carbonate ion acacia magnesium stearate maltodextrin sucrose az036

Indications and Usage:

Use temporarily relieves: heartburn sour stomach acid indigestion upset stomach associated with these symptoms

Warnings:

Warnings do not use more than 18 tablets in a 24 hour period or use the maximum dosage for more than two weeks except under the advice and supervision of a doctor ask a doctor or pharmacist before use if you are taking any prescription drugs. antacids may interact with certain prescription drugs if pregnant or breast-feeding, ask a health professional before use. keep out of reach of children.

Do Not Use:

Warnings do not use more than 18 tablets in a 24 hour period or use the maximum dosage for more than two weeks except under the advice and supervision of a doctor ask a doctor or pharmacist before use if you are taking any prescription drugs. antacids may interact with certain prescription drugs if pregnant or breast-feeding, ask a health professional before use. keep out of reach of children.

Dosage and Administration:

Directions adults: chew two to four tablets as symptoms occur; repeat hourly if symptoms return or as directed by a doctor. children under 12 years: ask a doctor.

Package Label Principal Display Panel:

Principal display panel - 100 tablet box product #1142 mint flavored antacid active ingredient: calcium carbonate stomach acid neutralizer great tasting, chewable tablets rich in calcium relieves upset stomach, acid indigestion and heartburn these quality comfort tablets are formulated and packaged for use in the workplace and meet ansi z308.1-2015 standards. they are sealed in tamper-evident packets for safety and convenience. 100 tablets • 2 tablets per packet principal display panel - 100 tablet box

Principal display panel - 250 tablet box product #1144 mint flavored antacid active ingredient: calcium carbonate stomach acid neutralizer great tasting, chewable tablets rich in calcium relieves upset stomach, acid indigestion and heartburn these quality comfort tablets are formulated and packaged for use in the workplace and meet ansi z308.1-2015 standards. they are sealed in tamper-evident packets for safety and convenience. 250 tablets • 2 tablets per packet principal display panel - 250 tablet box

Further Questions:

Questions? 1-866-651-3660 monday-friday 8:00am-5:00pm est


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.